Abstract
Plasma and buffy-coat vitamin C were estimated in 158 samples from 139 lung-cancer patients, at all stages of the disease. Most samples showed hypovitaminosis C in both estimations: 64% had plasma, and 25% buffy-coat values below the thresholds for incipient clinical scurvy (0.3 mg% and 10 micrograms/10(8) cells respectively). Levels were diet-dependent and could be increased by oral supplements. Levels were low both in tumour-bearing patients and in those clinically free of disease after resection. The latter had particularly low values during the first 6 months, indicating the utilization of vitamin C in surgical repair. The vitamin C content of 13 primary lung tumours was assayed: tumours had a higher vitamin C content (mean 111.6 +/- 55.1 micrograms/g tissue) than normal lung (58.5 +/- 20.4 micrograms/g). Mononuclear cells from normal individuals show a higher vitamin C content than polymorphs, but in lung-cancer patients the expected correlation of buffy-coat vitamin C with the proportion of lymphocytes in peripheral blood was obscured by an inverse correlation in patients with relative lymphocytosis (greater than or equal to 25% lymphocytes), confirmed by an inverse correlation of the proportion of lymphocytes in peripheral blood with mononuclear-cell vitamin C in 14 patients in whom this was measured. These correlations were unaffected by controlling for plasma values, and indicate the utilization of vitamin C in lymphocyte-related anti-tumour mechanisms. Vitamin C is necessary for phagocytosis and for the expression of cell-mediated immunity. In view of the increasing circumstantial evidence that immune mechanisms exert some measure of control on tumour extension and metastasis in man, the effect of supplementation with vitamin C in lung-cancer patients on survival should be tested in a clinical trial.
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Anthony, H., Schorah, C. Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 46, 354–367 (1982). https://doi.org/10.1038/bjc.1982.211
Issue Date:
DOI: https://doi.org/10.1038/bjc.1982.211
- Springer Nature Limited
This article is cited by
-
Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions
Journal of Biomedical Science (2017)
-
The epigenetic role of vitamin C in health and disease
Cellular and Molecular Life Sciences (2016)
-
A simple method for plasma total vitamin C analysis suitable for routine clinical laboratory use
Nutrition Journal (2015)
-
Appropriate vitamin D loading regimen for patients with advanced lung cancer
Nutrition Journal (2015)
-
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
Journal of Translational Medicine (2014)